Comments
Loading...
Aptorum Gr (APM) Forecast
NewsEarningsAptorum Gr (APM) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestAptorum Gr (NASDAQ:APM) Stock Quotes, Forecast and News Summary
Aptorum Gr Stock (NASDAQ: APM) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Aptorum Gr (APM) stock?
You can purchase shares of Aptorum Gr (NASDAQ:APM) through any online brokerage.
Who are Aptorum Gr (APM) competitors?
Other companies in Aptorum Gr’s space includes: CERo Therapeutics Hldgs (NASDAQ:CERO), Syros Pharmaceuticals (NASDAQ:SYRS), Galecto (NASDAQ:GLTO), Alzamend Neuro (NASDAQ:ALZN) and Quoin Pharmaceuticals (NASDAQ:QNRX).
What is the forecast, or price target, for Aptorum Gr (APM) stock?
Aptorum Gr has a consensus price target of $8.00.
What is the current price for Aptorum Gr (APM)?
The stock price for Aptorum Gr (NASDAQ: APM) is $1.165 last updated January 23, 2025 at 11:54 AM EST.
Does Aptorum Gr (APM) pay a dividend?
There are no upcoming dividends for Aptorum Gr.
When is Aptorum Gr (NASDAQ:APM) reporting earnings?
Aptorum Gr’s H1 earnings are confirmed for Friday, December 20, 2024.
Is Aptorum Gr (APM) going to split?
There is no upcoming split for Aptorum Gr.
What sector and industry does Aptorum Gr (APM) operate in?
Aptorum Gr is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.